1. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90(6):967-73. https://doi.org/10.1016/S0029-7844(97)00534-6 https://pubmed.ncbi.nlm.nih.gov/9397113 
2. Sabry M, Al-Hendy A. Medical treatment of uterine leiomyoma. Reprod Sci. 2012;19(4):339-53. https://doi.org/10.1177/1933719111432867 https://pubmed.ncbi.nlm.nih.gov/22378865 
3. Parker WH. Uterine myomas: management. Fertil Steril. 2007;88(2):255-71. https://doi.org/10.1016/j.fertnstert.2007.06.044 https://pubmed.ncbi.nlm.nih.gov/17658523 
4. Talaulikar VS, Manyonda I. Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2012;165(2):135-40. https://doi.org/10.1016/j.ejogrb.2012.07.023 https://pubmed.ncbi.nlm.nih.gov/22901974 
5. Sankaran S, Manyonda IT. Medical management of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):655-76. https://doi.org/10.1016/j.bpobgyn.2008.03.001 https://pubmed.ncbi.nlm.nih.gov/18468953 
6. Trefoux Bourdet A, Luton D, Koskas M. Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence. Int J Womens Health. 2015;7:321-30. https://doi.org/10.2147/IJWH.S50016 https://pubmed.ncbi.nlm.nih.gov/25848323 
7. Ribič-Pucelj M, Tomaževič T, Vogler A. Laparoskopska miomektomija. In: Ribič-Pucelj M, Pegan V, Pašić RP. Endoskopske operacije v ginekologiji. Radovljica: Didakta; 2007. pp. 207-15. 
8. Brun JL, Rajaonarison J, Froeliger A, Monseau-Thiburce AC, Randriamboavonjy R, Vogler A. Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy. Eur J Obstet Gynecol Reprod Biol. 2018;222:13-8. https://doi.org/10.1016/j.ejogrb.2017.12.033 https://pubmed.ncbi.nlm.nih.gov/29328939 
9. Sinai Talaulikar V, Belli AM, Manyonda I. GnRH agonists: do they have a place in the modern management of fibroid disease? J Obstet Gynaecol India. 2012;62(5):506-10. https://doi.org/10.1007/s13224-012-0206-0 https://pubmed.ncbi.nlm.nih.gov/24082548 
10. Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG. 2002;109(10):1097-108. https://doi.org/10.1111/j.1471-0528.2002.01225.x https://pubmed.ncbi.nlm.nih.gov/12387461 
11. Mavrelos D, Ben-Nagi J, Davies A, Lee C, Salim R, Jurkovic D. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial. Hum Reprod. 2010;25(9):2264-9. https://doi.org/10.1093/humrep/deq188 https://pubmed.ncbi.nlm.nih.gov/20663795 
12. Donnez J, Vázquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, et al.; PEARL III and PEARL III Extension Study Group. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014;101(6):1565-73.e1. https://doi.org/10.1016/j.fertnstert.2014.02.008 https://pubmed.ncbi.nlm.nih.gov/24630081 
13. Donnez J, Donnez O, Matule D, Ahrendt HJ, Hudecek R, Zatik J, et al. Long-term medical management of uterine fibroids with ulipristal acetate. Fertil Steril. 2016;105(1):165-173.e4. https://doi.org/10.1016/j.fertnstert.2015.09.032 https://pubmed.ncbi.nlm.nih.gov/26477496 
14. Powell M, Dutta D. Esmya ® and the PEARL studies: A review. Womens Health (Lond). 2016;12(6):544-8. https://doi.org/10.1177/1745505717692591 https://pubmed.ncbi.nlm.nih.gov/29334010 
15. Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, et al.; PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366(5):421-32. https://doi.org/10.1056/NEJMoa1103180 https://pubmed.ncbi.nlm.nih.gov/22296076 
16. Biglia N, Carinelli S, Maiorana A, D’Alonzo M, Lo Monte G, Marci R. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Devel Ther. 2014;8:285-92. https://doi.org/10.2147/DDDT.S54565 https://pubmed.ncbi.nlm.nih.gov/24591818 
17. Fiscella J, Bonfiglio T, Winters P, Eisinger SH, Fiscella K. Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone. Hum Pathol. 2011;42(7):947-53. https://doi.org/10.1016/j.humpath.2010.11.003 https://pubmed.ncbi.nlm.nih.gov/21315422 
18. Williams AR, Bergeron C, Barlow DH, Ferenczy A. Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate. Int J Gynecol Pathol. 2012;31(6):556-69. https://doi.org/10.1097/PGP.0b013e318251035b https://pubmed.ncbi.nlm.nih.gov/23018219 
19. Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, et al.; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366(5):409-20. https://doi.org/10.1056/NEJMoa1103182 https://pubmed.ncbi.nlm.nih.gov/22296075 
20. Sabry M, Al-Hendy A. Innovative oral treatments of uterine leiomyoma. Obstet Gynecol Int. 2012;2012:943635. https://doi.org/10.1155/2012/943635 https://pubmed.ncbi.nlm.nih.gov/22518167 
21. Duhan N. Current and emerging treatments for uterine myoma - an update. Int J Womens Health. 2011;3(1):231-41. https://doi.org/10.2147/IJWH.S15710 https://pubmed.ncbi.nlm.nih.gov/21892334 
22. Ginsburg ES, Benson CB, Garfield JM, Gleason RE, Friedman AJ. The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril. 1993;60(6):956-62. https://doi.org/10.1016/S0015-0282(16)56392-4 https://pubmed.ncbi.nlm.nih.gov/8243699 
23. Leone Roberti Maggiore U, Scala C, Venturini PL, Ferrero S. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study. Eur J Obstet Gynecol Reprod Biol. 2014;181:157-62. https://doi.org/10.1016/j.ejogrb.2014.07.040 https://pubmed.ncbi.nlm.nih.gov/25150954 
24. Donnez J, Hudecek R, Donnez O, Matule D, Arhendt HJ, Zatik J, et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril. 2015;103(2):519-27.e3. https://doi.org/10.1016/j.fertnstert.2014.10.038 https://pubmed.ncbi.nlm.nih.gov/25542821 
25. Rabe T, Ahrendt HJ, Albring C, Bitzer J, Bouchard P, Cirkel U, et al. Ulipristal acetate for symptomatic uterine fibroids and myoma-related hypermenorrhea: joint statement by the german society for gynecological endocrinology and reproductive medicine (DGGEF) and the german professional association of gynecologist (BVF). J Reproduktionsmed Endokrinol. 2013;10(Special Issue 1):82-101. 
26. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378(9800):1396-407. https://doi.org/10.1016/S0140-6736(11)61381-0 https://pubmed.ncbi.nlm.nih.gov/21982521 
27. European medicines agency. Science medicines health. Esmya (ulipristalacetat). Available from: http://www.ema.europa.eu/docs/sl_SI/document_library/EPAR_-_Summary_for_the_public/human/002041/WC500124089.pdf 
28. European medicines agency. Science medicines health. Priloga 1. Povzetek glavnih značilnosti zdravila. Available from: http://www.ema.europa.eu/docs/sl_SI/document_library/EPAR_-_Product_Information/human/002041/WC500124085.pdf 
29. European medicines agency. Science medicines health. PAssessment report on provisional measures. Available from: https://www.ema.europa.eu/en/documents/referral/esmya-article-20-procedure-assessment-report-provisional-measures_en.pdf 
30. Luyckx M, Squifflet JL, Jadoul P, Votino R, Dolmans MM, Donnez J. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertil Steril. 2014;102(5):1404-9. https://doi.org/10.1016/j.fertnstert.2014.07.1253 https://pubmed.ncbi.nlm.nih.gov/25241376 
31. Monleón J, Martínez-Varea A, Galliano D, Pellicer A. Successful pregnancy after treatment with ulipristal acetate for uterine fibroids. Case Rep Obstet Gynecol. 2014;2014:314587. https://doi.org/10.1155/2014/314587 https://pubmed.ncbi.nlm.nih.gov/25143845 
32. Murad K. Spontaneous pregnancy following ulipristal acetate treatment in a woman with a symptomatic uterine fibroid. J Obstet Gynaecol Can. 2016;38(1):75-9. https://doi.org/10.1016/j.jogc.2015.11.004 https://pubmed.ncbi.nlm.nih.gov/26872760 
